Global Targeted Antitumor Drugs Market Growth 2022-2028
Targeted antitumor drugs use specific structural molecules of tumor tissues or cells as targets to achieve the purpose of directly killing tumor cells, and have the advantages of high specificity, high selectivity, light side reactions and high efficacy/toxicity ratio compared with chemotherapy drugs
The global market for Targeted Antitumor Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Targeted Antitumor Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Targeted Antitumor Drugs players cover Roche, Celgene, Novartis, Johnson & Johnson and Lilly, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Targeted Antitumor Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Targeted Antitumor Drugs market, with both quantitative and qualitative data, to help readers understand how the Targeted Antitumor Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Targeted Antitumor Drugs market and forecasts the market size by Type (Macromolecular Targeted Antitumor Drugs and Small Molecule Targeted Antitumor Drugs,), by Application (Lung Cancer, Lymphoma, Breast Cancer and Leukaemia), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Macromolecular Targeted Antitumor Drugs
Small Molecule Targeted Antitumor Drugs
Segmentation by application
Lung Cancer
Lymphoma
Breast Cancer
Leukaemia
Prostate Cancer
Multiple Bone Marrow Cancer
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Roche
Celgene
Novartis
Johnson & Johnson
Lilly
AstraZeneca plc.
Betta Pharmaceuticals
Chapter Introduction
Chapter 1: Scope of Targeted Antitumor Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Targeted Antitumor Drugs market size (sales and revenue) and CAGR, Targeted Antitumor Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Targeted Antitumor Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Targeted Antitumor Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Targeted Antitumor Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Roche, Celgene, Novartis, Johnson & Johnson, Lilly, AstraZeneca plc. and Betta Pharmaceuticals, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted Antitumor Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Targeted Antitumor Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Targeted Antitumor Drugs by Country/Region, 2017, 2022 & 2028
2.2 Targeted Antitumor Drugs Segment by Type
2.2.1 Macromolecular Targeted Antitumor Drugs
2.2.2 Small Molecule Targeted Antitumor Drugs
2.3 Targeted Antitumor Drugs Sales by Type
2.3.1 Global Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Targeted Antitumor Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Targeted Antitumor Drugs Sale Price by Type (2017-2022)
2.4 Targeted Antitumor Drugs Segment by Application
2.4.1 Lung Cancer
2.4.2 Lymphoma
2.4.3 Breast Cancer
2.4.4 Leukaemia
2.4.5 Prostate Cancer
2.4.6 Multiple Bone Marrow Cancer
2.4.7 Others
2.5 Targeted Antitumor Drugs Sales by Application
2.5.1 Global Targeted Antitumor Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Targeted Antitumor Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Targeted Antitumor Drugs Sale Price by Application (2017-2022)
3 Global Targeted Antitumor Drugs by Company
3.1 Global Targeted Antitumor Drugs Breakdown Data by Company
3.1.1 Global Targeted Antitumor Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Targeted Antitumor Drugs Sales Market Share by Company (2020-2022)
3.2 Global Targeted Antitumor Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Targeted Antitumor Drugs Revenue by Company (2020-2022)
3.2.2 Global Targeted Antitumor Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Targeted Antitumor Drugs Sale Price by Company
3.4 Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted Antitumor Drugs Product Location Distribution
3.4.2 Players Targeted Antitumor Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Targeted Antitumor Drugs by Geographic Region
4.1 World Historic Targeted Antitumor Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Targeted Antitumor Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Targeted Antitumor Drugs Annual Revenue by Geographic Region
4.2 World Historic Targeted Antitumor Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Targeted Antitumor Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Targeted Antitumor Drugs Annual Revenue by Country/Region
4.3 Americas Targeted Antitumor Drugs Sales Growth
4.4 APAC Targeted Antitumor Drugs Sales Growth
4.5 Europe Targeted Antitumor Drugs Sales Growth
4.6 Middle East & Africa Targeted Antitumor Drugs Sales Growth
5 Americas
5.1 Americas Targeted Antitumor Drugs Sales by Country
5.1.1 Americas Targeted Antitumor Drugs Sales by Country (2017-2022)
5.1.2 Americas Targeted Antitumor Drugs Revenue by Country (2017-2022)
5.2 Americas Targeted Antitumor Drugs Sales by Type
5.3 Americas Targeted Antitumor Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Antitumor Drugs Sales by Region
6.1.1 APAC Targeted Antitumor Drugs Sales by Region (2017-2022)
6.1.2 APAC Targeted Antitumor Drugs Revenue by Region (2017-2022)
6.2 APAC Targeted Antitumor Drugs Sales by Type
6.3 APAC Targeted Antitumor Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Targeted Antitumor Drugs by Country
7.1.1 Europe Targeted Antitumor Drugs Sales by Country (2017-2022)
7.1.2 Europe Targeted Antitumor Drugs Revenue by Country (2017-2022)
7.2 Europe Targeted Antitumor Drugs Sales by Type
7.3 Europe Targeted Antitumor Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted Antitumor Drugs by Country
8.1.1 Middle East & Africa Targeted Antitumor Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Targeted Antitumor Drugs Sales by Type
8.3 Middle East & Africa Targeted Antitumor Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs
10.3 Manufacturing Process Analysis of Targeted Antitumor Drugs
10.4 Industry Chain Structure of Targeted Antitumor Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted Antitumor Drugs Distributors
11.3 Targeted Antitumor Drugs Customer
12 World Forecast Review for Targeted Antitumor Drugs by Geographic Region
12.1 Global Targeted Antitumor Drugs Market Size Forecast by Region
12.1.1 Global Targeted Antitumor Drugs Forecast by Region (2023-2028)
12.1.2 Global Targeted Antitumor Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Targeted Antitumor Drugs Forecast by Type
12.7 Global Targeted Antitumor Drugs Forecast by Application
13 Key Players Analysis
13.1 Roche
13.1.1 Roche Company Information
13.1.2 Roche Targeted Antitumor Drugs Product Offered
13.1.3 Roche Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Roche Main Business Overview
13.1.5 Roche Latest Developments
13.2 Celgene
13.2.1 Celgene Company Information
13.2.2 Celgene Targeted Antitumor Drugs Product Offered
13.2.3 Celgene Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Celgene Main Business Overview
13.2.5 Celgene Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Targeted Antitumor Drugs Product Offered
13.3.3 Novartis Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Information
13.4.2 Johnson & Johnson Targeted Antitumor Drugs Product Offered
13.4.3 Johnson & Johnson Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Johnson & Johnson Main Business Overview
13.4.5 Johnson & Johnson Latest Developments
13.5 Lilly
13.5.1 Lilly Company Information
13.5.2 Lilly Targeted Antitumor Drugs Product Offered
13.5.3 Lilly Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Lilly Main Business Overview
13.5.5 Lilly Latest Developments
13.6 AstraZeneca plc.
13.6.1 AstraZeneca plc. Company Information
13.6.2 AstraZeneca plc. Targeted Antitumor Drugs Product Offered
13.6.3 AstraZeneca plc. Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 AstraZeneca plc. Main Business Overview
13.6.5 AstraZeneca plc. Latest Developments
13.7 Betta Pharmaceuticals
13.7.1 Betta Pharmaceuticals Company Information
13.7.2 Betta Pharmaceuticals Targeted Antitumor Drugs Product Offered
13.7.3 Betta Pharmaceuticals Targeted Antitumor Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Betta Pharmaceuticals Main Business Overview
13.7.5 Betta Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Targeted Antitumor Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Targeted Antitumor Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Macromolecular Targeted Antitumor Drugs
Table 4. Major Players of Small Molecule Targeted Antitumor Drugs
Table 5. Global Targeted Antitumor Drugs Sales by Type (2017-2022) & (K Units)
Table 6. Global Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Targeted Antitumor Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Targeted Antitumor Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Targeted Antitumor Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Targeted Antitumor Drugs Sales by Application (2017-2022) & (K Units)
Table 11. Global Targeted Antitumor Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Targeted Antitumor Drugs Revenue by Application (2017-2022)
Table 13. Global Targeted Antitumor Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Targeted Antitumor Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Targeted Antitumor Drugs Sales by Company (2020-2022) & (K Units)
Table 16. Global Targeted Antitumor Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Targeted Antitumor Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Targeted Antitumor Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Targeted Antitumor Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Targeted Antitumor Drugs Producing Area Distribution and Sales Area
Table 21. Players Targeted Antitumor Drugs Products Offered
Table 22. Targeted Antitumor Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Targeted Antitumor Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Targeted Antitumor Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Targeted Antitumor Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Targeted Antitumor Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Targeted Antitumor Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Targeted Antitumor Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Targeted Antitumor Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Targeted Antitumor Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Targeted Antitumor Drugs Sales by Country (2017-2022) & (K Units)
Table 34. Americas Targeted Antitumor Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Targeted Antitumor Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Targeted Antitumor Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Targeted Antitumor Drugs Sales by Type (2017-2022) & (K Units)
Table 38. Americas Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Targeted Antitumor Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Americas Targeted Antitumor Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Targeted Antitumor Drugs Sales by Region (2017-2022) & (K Units)
Table 42. APAC Targeted Antitumor Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Targeted Antitumor Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Targeted Antitumor Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Targeted Antitumor Drugs Sales by Type (2017-2022) & (K Units)
Table 46. APAC Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Targeted Antitumor Drugs Sales by Application (2017-2022) & (K Units)
Table 48. APAC Targeted Antitumor Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Targeted Antitumor Drugs Sales by Country (2017-2022) & (K Units)
Table 50. Europe Targeted Antitumor Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Targeted Antitumor Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Targeted Antitumor Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Targeted Antitumor Drugs Sales by Type (2017-2022) & (K Units)
Table 54. Europe Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Targeted Antitumor Drugs Sales by Application (2017-2022) & (K Units)
Table 56. Europe Targeted Antitumor Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Targeted Antitumor Drugs Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Targeted Antitumor Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Targeted Antitumor Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Targeted Antitumor Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Targeted Antitumor Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Targeted Antitumor Drugs
Table 66. Key Market Challenges & Risks of Targeted Antitumor Drugs
Table 67. Key Industry Trends of Targeted Antitumor Drugs
Table 68. Targeted Antitumor Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Targeted Antitumor Drugs Distributors List
Table 71. Targeted Antitumor Drugs Customer List
Table 72. Global Targeted Antitumor Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Targeted Antitumor Drugs Sales Market Forecast by Region
Table 74. Global Targeted Antitumor Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Targeted Antitumor Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Targeted Antitumor Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Targeted Antitumor Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Targeted Antitumor Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Targeted Antitumor Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Targeted Antitumor Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Targeted Antitumor Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Targeted Antitumor Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Targeted Antitumor Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Targeted Antitumor Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Targeted Antitumor Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Targeted Antitumor Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Targeted Antitumor Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Targeted Antitumor Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Targeted Antitumor Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. Roche Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. Roche Targeted Antitumor Drugs Product Offered
Table 94. Roche Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Roche Main Business
Table 96. Roche Latest Developments
Table 97. Celgene Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Celgene Targeted Antitumor Drugs Product Offered
Table 99. Celgene Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Celgene Main Business
Table 101. Celgene Latest Developments
Table 102. Novartis Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Novartis Targeted Antitumor Drugs Product Offered
Table 104. Novartis Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Novartis Main Business
Table 106. Novartis Latest Developments
Table 107. Johnson & Johnson Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Johnson & Johnson Targeted Antitumor Drugs Product Offered
Table 109. Johnson & Johnson Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Johnson & Johnson Main Business
Table 111. Johnson & Johnson Latest Developments
Table 112. Lilly Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Lilly Targeted Antitumor Drugs Product Offered
Table 114. Lilly Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Lilly Main Business
Table 116. Lilly Latest Developments
Table 117. AstraZeneca plc. Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. AstraZeneca plc. Targeted Antitumor Drugs Product Offered
Table 119. AstraZeneca plc. Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. AstraZeneca plc. Main Business
Table 121. AstraZeneca plc. Latest Developments
Table 122. Betta Pharmaceuticals Basic Information, Targeted Antitumor Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Betta Pharmaceuticals Targeted Antitumor Drugs Product Offered
Table 124. Betta Pharmaceuticals Targeted Antitumor Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Betta Pharmaceuticals Main Business
Table 126. Betta Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Targeted Antitumor Drugs
Figure 2. Targeted Antitumor Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Targeted Antitumor Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Targeted Antitumor Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Targeted Antitumor Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Macromolecular Targeted Antitumor Drugs
Figure 10. Product Picture of Small Molecule Targeted Antitumor Drugs
Figure 11. Global Targeted Antitumor Drugs Sales Market Share by Type in 2021
Figure 12. Global Targeted Antitumor Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Targeted Antitumor Drugs Consumed in Lung Cancer
Figure 14. Global Targeted Antitumor Drugs Market: Lung Cancer (2017-2022) & (K Units)
Figure 15. Targeted Antitumor Drugs Consumed in Lymphoma
Figure 16. Global Targeted Antitumor Drugs Market: Lymphoma (2017-2022) & (K Units)
Figure 17. Targeted Antitumor Drugs Consumed in Breast Cancer
Figure 18. Global Targeted Antitumor Drugs Market: Breast Cancer (2017-2022) & (K Units)
Figure 19. Targeted Antitumor Drugs Consumed in Leukaemia
Figure 20. Global Targeted Antitumor Drugs Market: Leukaemia (2017-2022) & (K Units)
Figure 21. Targeted Antitumor Drugs Consumed in Prostate Cancer
Figure 22. Global Targeted Antitumor Drugs Market: Prostate Cancer (2017-2022) & (K Units)
Figure 23. Targeted Antitumor Drugs Consumed in Multiple Bone Marrow Cancer
Figure 24. Global Targeted Antitumor Drugs Market: Multiple Bone Marrow Cancer (2017-2022) & (K Units)
Figure 25. Targeted Antitumor Drugs Consumed in Others
Figure 26. Global Targeted Antitumor Drugs Market: Others (2017-2022) & (K Units)
Figure 27. Global Targeted Antitumor Drugs Sales Market Share by Application (2017-2022)
Figure 28. Global Targeted Antitumor Drugs Revenue Market Share by Application in 2021
Figure 29. Targeted Antitumor Drugs Revenue Market by Company in 2021 ($ Million)
Figure 30. Global Targeted Antitumor Drugs Revenue Market Share by Company in 2021
Figure 31. Global Targeted Antitumor Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 32. Global Targeted Antitumor Drugs Revenue Market Share by Geographic Region in 2021
Figure 33. Global Targeted Antitumor Drugs Sales Market Share by Region (2017-2022)
Figure 34. Global Targeted Antitumor Drugs Revenue Market Share by Country/Region in 2021
Figure 35. Americas Targeted Antitumor Drugs Sales 2017-2022 (K Units)
Figure 36. Americas Targeted Antitumor Drugs Revenue 2017-2022 ($ Millions)
Figure 37. APAC Targeted Antitumor Drugs Sales 2017-2022 (K Units)
Figure 38. APAC Targeted Antitumor Drugs Revenue 2017-2022 ($ Millions)
Figure 39. Europe Targeted Antitumor Drugs Sales 2017-2022 (K Units)
Figure 40. Europe Targeted Antitumor Drugs Revenue 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Targeted Antitumor Drugs Sales 2017-2022 (K Units)
Figure 42. Middle East & Africa Targeted Antitumor Drugs Revenue 2017-2022 ($ Millions)
Figure 43. Americas Targeted Antitumor Drugs Sales Market Share by Country in 2021
Figure 44. Americas Targeted Antitumor Drugs Revenue Market Share by Country in 2021
Figure 45. United States Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Canada Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Mexico Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Brazil Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. APAC Targeted Antitumor Drugs Sales Market Share by Region in 2021
Figure 50. APAC Targeted Antitumor Drugs Revenue Market Share by Regions in 2021
Figure 51. China Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. Japan Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. South Korea Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Southeast Asia Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. India Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Australia Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Europe Targeted Antitumor Drugs Sales Market Share by Country in 2021
Figure 58. Europe Targeted Antitumor Drugs Revenue Market Share by Country in 2021
Figure 59. Germany Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. France Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. UK Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Italy Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Russia Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Middle East & Africa Targeted Antitumor Drugs Sales Market Share by Country in 2021
Figure 65. Middle East & Africa Targeted Antitumor Drugs Revenue Market Share by Country in 2021
Figure 66. Egypt Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 67. South Africa Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 68. Israel Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 69. Turkey Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 70. GCC Country Targeted Antitumor Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Targeted Antitumor Drugs in 2021
Figure 72. Manufacturing Process Analysis of Targeted Antitumor Drugs
Figure 73. Industry Chain Structure of Targeted Antitumor Drugs
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets